ID

29214

Description

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs; ODM derived from: https://clinicaltrials.gov/show/NCT00537277

Lien

https://clinicaltrials.gov/show/NCT00537277

Mots-clés

Versions (1)
  1. 08/03/2018 08/03/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

8 mars 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT00537277

Anglais

Eligibility Diabetes NCT00537277

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00537277
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus for more than 12 months
Description

Non-Insulin-Dependent Diabetes Mellitus Disease length

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
hba1c: 7.5 - 11.0%
Description

Glucohemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
an antidiabetic regimen that has been stable for at least 3 months prior to screening
Description

Antidiabetics Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0205360
an antidiabetic regimen that includes a minimum of 2 oral anti-diabetic drugs (oads) or 1 oad plus evening or bedtime basal insulin
Description

Antidiabetics Oral Quantity | Evening Basal insulin | Bedtime Basal insulin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0587117
UMLS CUI [2,2]
C0650607
UMLS CUI [3,1]
C0521112
UMLS CUI [3,2]
C0650607
oads dosed at 50% or more of the maximum recommended dose
Description

Antidiabetics Oral Dosage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0178602
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of any insulin preparations other than nph or glargine within the past 6 months
Description

Insulin | Exception NPH insulin | Exception Insulin Glargine

Type de données

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0021658
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0907402
use of more than 60 units of insulin per day
Description

Insulin U/day Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0456683
UMLS CUI [1,3]
C1265611
morning time insulin administration
Description

Administration of insulin Morning

Type de données

boolean

Alias
UMLS CUI [1,1]
C0199782
UMLS CUI [1,2]
C0332170
use of more than one insulin dose daily
Description

Insulin Dose Quantity per day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0439505
Retour au début de la page

Similar models

Eligibility Diabetes NCT00537277

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00537277
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes mellitus for more than 12 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hba1c: 7.5 - 11.0%
boolean
C0202054 (UMLS CUI [1])
Antidiabetics Stable
Item
an antidiabetic regimen that has been stable for at least 3 months prior to screening
boolean
C0935929 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Antidiabetics Oral Quantity | Evening Basal insulin | Bedtime Basal insulin
Item
an antidiabetic regimen that includes a minimum of 2 oral anti-diabetic drugs (oads) or 1 oad plus evening or bedtime basal insulin
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0587117 (UMLS CUI [2,1])
C0650607 (UMLS CUI [2,2])
C0521112 (UMLS CUI [3,1])
C0650607 (UMLS CUI [3,2])
Antidiabetics Oral Dosage
Item
oads dosed at 50% or more of the maximum recommended dose
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Insulin | Exception NPH insulin | Exception Insulin Glargine
Item
use of any insulin preparations other than nph or glargine within the past 6 months
boolean
C0021641 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0021658 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0907402 (UMLS CUI [3,2])
Insulin U/day Quantity
Item
use of more than 60 units of insulin per day
boolean
C0021641 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Administration of insulin Morning
Item
morning time insulin administration
boolean
C0199782 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
Insulin Dose Quantity per day
Item
use of more than one insulin dose daily
boolean
C0021641 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0439505 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial